ABL Financial Statements From 2010 to 2025
| 298380 Stock | KRW 40,550 600.00 1.46% |
Check ABL Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ABL Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . ABL financial statements analysis is a perfect complement when working with ABL Bio Valuation or Volatility modules.
ABL |
ABL Bio Company Shares Outstanding Analysis
ABL Bio's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current ABL Bio Shares Outstanding | 45.3 M |
Most of ABL Bio's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABL Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, ABL Bio has 45.3 M of shares currently outstending. This is 74.91% lower than that of the Healthcare sector and 57.6% lower than that of the Biotechnology industry. The shares outstanding for all Republic of Korea stocks is 92.08% higher than that of the company.
ABL Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ABL Bio's current stock value. Our valuation model uses many indicators to compare ABL Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ABL Bio competition to find correlations between indicators driving ABL Bio's intrinsic value. More Info.ABL Bio is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value ABL Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ABL Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About ABL Bio Financial Statements
ABL Bio stakeholders use historical fundamental indicators, such as ABL Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although ABL Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in ABL Bio's assets and liabilities are reflected in the revenues and expenses on ABL Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ABL Bio. Please read more on our technical analysis and fundamental analysis pages.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with ABL Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABL Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABL Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with ABL Stock
Moving against ABL Stock
| 0.86 | 235980 | MedPacto | PairCorr |
| 0.85 | 244460 | OLIPASS | PairCorr |
| 0.66 | 302440 | SK Bioscience | PairCorr |
| 0.59 | 334970 | Prestige Biologics | PairCorr |
| 0.41 | 144510 | Green Cross Lab | PairCorr |
The ability to find closely correlated positions to ABL Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABL Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABL Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABL Bio to buy it.
The correlation of ABL Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABL Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABL Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABL Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ABL Stock
ABL Bio financial ratios help investors to determine whether ABL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABL with respect to the benefits of owning ABL Bio security.